 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Dendur Capital LP bought a new position in shares of CM Life Sciences II Inc. (NASDAQ:CMII)
  in the second quarter, according to the company in its most recent filing with the
  Securities  Exchange Commission. The firm bought 300,000 shares of the companys
  stock, valued at approximately $3...


Dendur Capital LP Makes New $3.95 Million Investment in CM Life Sciences II Inc. (NASDAQ:CMII)

---
- CM Life Sciences II (NASDAQ:CMII) and IQVIA (NYSE:IQV) are both unclassified companies,
  but which is the superior investment? We will compare the two businesses based on
  the strength of their institutional ownership, earnings, valuation, risk, profitability,
  analyst recommendations and dividends. ...


Head-To-Head Comparison: CM Life Sciences II (NASDAQ:CMII) vs. IQVIA (NYSE:IQV)

---
- SomaLogic has completed its business combination with SPAC CM Life Sciences II (CMII).The
  combined company called SomaLogic will begin trading on the Nasdaq today under the
  symbols...


SomaLogic debuts on Nasdaq today after business combination with CM Life Sciences II

---
- CM Life Sciences II Inc. (NASDAQ:CMII) shares were down 0.4% during trading on Wednesday
  . The company traded as low as $9.97 and last traded at $9.99. Approximately 119,752
  shares changed hands during trading, an increase of 241% from the average daily
  volume of 35,102 shares. The stock had ...


CM Life Sciences II (NASDAQ:CMII) Stock Price Down 0.4%

---
- SomaLogic, CM Life Sciences II (CMII) and Twist Bioscience (TWST) announce a collaboration
  aimed at creating novel antibodies and enabling innovative drug discovery based
  on key...


Twist Bioscience inks collaboration agreement to create novel antibodies

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company was founded by Larry Gold in 2000 and is headquartered in Boulder, CO.

Market Cap	$460.38M
Volume (M)	166,471.00
52-Wk High	$3.79
52-Wk Low	$1.73

Current Price	$2.44
Prev Close	$2.53
Open	$2.51
Dividend Yield	0.00%
50-Day Moving Average	$2.32
Beta	0.00
Avg. Volume	1.3M
PE Ratio	-3.49

52-Week High	$3.79
52-Week Low	$1.73
Market Capitalization	$460.38M
EPS	-$0.6988
Price to Book	0.93
Revenue Per Employee	$181,206.21
Enterprise Value/EBITDA	0.02

CMII CM Life Sciences II Inc

About

Feed

News

Fundamentals